Basel Medical (BMGL) Shares Outstanding (Weighted Average) (2024 - 2025)
Basel Medical (BMGL) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $26.3 million as the latest value for Q2 2025.
- Quarterly Shares Outstanding (Weighted Average) rose 118.81% to $26.3 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $26.3 million through Jun 2025, up 118.81% year-over-year, with the annual reading at $25.6 million for FY2025, 113.22% up from the prior year.
- Shares Outstanding (Weighted Average) hit $26.3 million in Q2 2025 for Basel Medical, up from $12.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $26.3 million in Q2 2025 to a low of $12.0 million in Q2 2024.